.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Merck
Baxter
Boehringer Ingelheim
Express Scripts
US Department of Justice
Chubb
Medtronic
Daiichi Sankyo
Fuji

Generated: December 14, 2017

DrugPatentWatch Database Preview

DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE Drug Profile

« Back to Dashboard

Which patents cover Dexamethasone Sodium Phosphate Preservative Free, and when can generic versions of Dexamethasone Sodium Phosphate Preservative Free launch?

Dexamethasone Sodium Phosphate Preservative Free is a drug marketed by Fresenius Kabi Usa and is included in one NDA.

The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.

Summary for DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE

Drug patent expirations by year for DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE

Pharmacology for DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi UsaDEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREEdexamethasone sodium phosphateINJECTABLE;INJECTION040491-001Apr 11, 2003APRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Chinese Patent Office
Teva
AstraZeneca
Moodys
Chubb
Cantor Fitzgerald
Harvard Business School
Johnson and Johnson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot